Internal Neuromodulation Devices Market Size to Hit USD 48.45 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Internal Neuromodulation Devices Market, By Device Type

7.1. Internal Neuromodulation Devices Market Revenue and Volume, by Device Type

7.1.1. Spinal Cord Stimulators (SCS)

7.1.1.1. Market Revenue and Volume Forecast

7.1.2. Deep Brain Stimulators (DBS)

7.1.2.1. Market Revenue and Volume Forecast

7.1.3. Vagus Nerve Stimulators (VNS)

7.1.3.1. Market Revenue and Volume Forecast

7.1.4. Sacral Nerve Stimulators (SNS)

7.1.4.1. Market Revenue and Volume Forecast

7.1.5. Gastric Electrical Stimulators (GES)

7.1.5.1. Market Revenue and Volume Forecast

7.1.6. Other Peripheral Nerve Stimulators (e.g., occipital, trigeminal)

7.1.6.1. Market Revenue and Volume Forecast

Chapter 8. Global Internal Neuromodulation Devices Market, By Application / Therapy Area

8.1. Internal Neuromodulation Devices Market Revenue and Volume, by Application / Therapy Area

8.1.1. Chronic Pain Management

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Parkinson’s Disease

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Epilepsy

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Essential Tremor

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Depression & Psychiatric Disorders

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Urinary & Fecal Incontinence

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Gastroparesis

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Other Neurological & Functional Disorders

8.1.8.1. Market Revenue and Volume Forecast

Chapter 9. Global Internal Neuromodulation Devices Market, By Technology / Stimulation Mode

9.1. Internal Neuromodulation Devices Market Revenue and Volume, by Technology / Stimulation Mode

9.1.1. Electrical Stimulation (traditional)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Magnetic / Adaptive Stimulation

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Closed-Loop / Responsive Neuromodulation

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Multi-site / Hybrid Stimulation Systems

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Internal Neuromodulation Devices Market, By Component

10.1. Internal Neuromodulation Devices Market Revenue and Volume, by Component

10.1.1. Implantable Pulse Generators (IPGs)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Leads & Electrodes

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Rechargeable vs. Non-rechargeable Batteries

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. External Controllers & Programmers

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Software & Data Analytics Platforms

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Internal Neuromodulation Devices Market, By Patient Demographics

11.1. Internal Neuromodulation Devices Market Revenue and Volume, by Patient Demographics

11.1.1. Adult Patients

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Geriatric Patients

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Pediatric Patients (selected epilepsy & movement disorder cases)

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Internal Neuromodulation Devices Market, By End-User

12.1. Internal Neuromodulation Devices Market Revenue and Volume, by End-User

12.1.1. Hospitals (neurosurgery & pain centers)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Specialty Clinics (neurology, psychiatry, pain management)

12.1.2.1. Market Revenue and Volume Forecast

Chapter 13. Global Internal Neuromodulation Devices Market, By Price / Product Tier

13.1. Internal Neuromodulation Devices Market Revenue and Volume, by Price / Product Tier

13.1.1. Standard Neuromodulation Systems (basic, lower-cost IPGs)

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Mid-tier Rechargeable Systems

13.1.2.1. Market Revenue and Volume Forecast

Chapter 14. Global Internal Neuromodulation Devices Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Device Type

14.1.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.1.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.1.4. Market Revenue and Volume Forecast, by Component

14.1.5. Market Revenue and Volume Forecast, by Patient Demographics

14.1.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.1.7. Market Revenue and Volume Forecast, by End-User

14.1.8. U.S.

14.1.8.1. Market Revenue and Volume Forecast, by Device Type

14.1.8.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.1.8.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.1.8.4. Market Revenue and Volume Forecast, by Component

14.1.8.5. Market Revenue and Volume Forecast, by Patient Demographics

14.1.8.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.1.8.7. Market Revenue and Volume Forecast, by End-User

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Device Type

14.1.9.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.1.9.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.1.9.4. Market Revenue and Volume Forecast, by Component

14.1.9.5. Market Revenue and Volume Forecast, by Patient Demographics

14.1.9.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.1.9.7. Market Revenue and Volume Forecast, by End-User

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Device Type

14.2.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.2.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.2.4. Market Revenue and Volume Forecast, by Component

14.2.5. Market Revenue and Volume Forecast, by Patient Demographics

14.2.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.2.7. Market Revenue and Volume Forecast, by End-User

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Device Type

14.2.8.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.2.8.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.2.8.4. Market Revenue and Volume Forecast, by Component

14.2.8.5. Market Revenue and Volume Forecast, by Patient Demographics

14.2.8.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.2.8.7. Market Revenue and Volume Forecast, by End-User

14.2.9. Germany

14.2.9.1. Market Revenue and Volume Forecast, by Device Type

14.2.9.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.2.9.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.2.9.4. Market Revenue and Volume Forecast, by Component

14.2.9.5. Market Revenue and Volume Forecast, by Patient Demographics

14.2.9.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.2.9.7. Market Revenue and Volume Forecast, by End-User

14.2.10. France

14.2.10.1. Market Revenue and Volume Forecast, by Device Type

14.2.10.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.2.10.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.2.10.4. Market Revenue and Volume Forecast, by Component

14.2.10.5. Market Revenue and Volume Forecast, by Patient Demographics

14.2.10.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.2.10.7. Market Revenue and Volume Forecast, by End-User

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Volume Forecast, by Device Type

14.2.11.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.2.11.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.2.11.4. Market Revenue and Volume Forecast, by Component

14.2.11.5. Market Revenue and Volume Forecast, by Patient Demographics

14.2.11.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.2.11.7. Market Revenue and Volume Forecast, by End-User

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Device Type

14.3.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.3.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.3.4. Market Revenue and Volume Forecast, by Component

14.3.5. Market Revenue and Volume Forecast, by Patient Demographics

14.3.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.3.7. Market Revenue and Volume Forecast, by End-User

14.3.8. India

14.3.8.1. Market Revenue and Volume Forecast, by Device Type

14.3.8.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.3.8.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.3.8.4. Market Revenue and Volume Forecast, by Component

14.3.8.5. Market Revenue and Volume Forecast, by Patient Demographics

14.3.8.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.3.8.7. Market Revenue and Volume Forecast, by End-User

14.3.9. China

14.3.9.1. Market Revenue and Volume Forecast, by Device Type

14.3.9.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.3.9.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.3.9.4. Market Revenue and Volume Forecast, by Component

14.3.9.5. Market Revenue and Volume Forecast, by Patient Demographics

14.3.9.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.3.9.7. Market Revenue and Volume Forecast, by End-User

14.3.10. Japan

14.3.10.1. Market Revenue and Volume Forecast, by Device Type

14.3.10.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.3.10.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.3.10.4. Market Revenue and Volume Forecast, by Component

14.3.10.5. Market Revenue and Volume Forecast, by Patient Demographics

14.3.10.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.3.10.7. Market Revenue and Volume Forecast, by End-User

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Volume Forecast, by Device Type

14.3.11.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.3.11.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.3.11.4. Market Revenue and Volume Forecast, by Component

14.3.11.5. Market Revenue and Volume Forecast, by Patient Demographics

14.3.11.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.3.11.7. Market Revenue and Volume Forecast, by End-User

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Device Type

14.4.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.4.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.4.4. Market Revenue and Volume Forecast, by Component

14.4.5. Market Revenue and Volume Forecast, by Patient Demographics

14.4.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.4.7. Market Revenue and Volume Forecast, by End-User

14.4.8. GCC

14.4.8.1. Market Revenue and Volume Forecast, by Device Type

14.4.8.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.4.8.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.4.8.4. Market Revenue and Volume Forecast, by Component

14.4.8.5. Market Revenue and Volume Forecast, by Patient Demographics

14.4.8.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.4.8.7. Market Revenue and Volume Forecast, by End-User

14.4.9. North Africa

14.4.9.1. Market Revenue and Volume Forecast, by Device Type

14.4.9.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.4.9.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.4.9.4. Market Revenue and Volume Forecast, by Component

14.4.9.5. Market Revenue and Volume Forecast, by Patient Demographics

14.4.9.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.4.9.7. Market Revenue and Volume Forecast, by End-User

14.4.10. South Africa

14.4.10.1. Market Revenue and Volume Forecast, by Device Type

14.4.10.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.4.10.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.4.10.4. Market Revenue and Volume Forecast, by Component

14.4.10.5. Market Revenue and Volume Forecast, by Patient Demographics

14.4.10.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.4.10.7. Market Revenue and Volume Forecast, by End-User

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Volume Forecast, by Device Type

14.4.11.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.4.11.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.4.11.4. Market Revenue and Volume Forecast, by Component

14.4.11.5. Market Revenue and Volume Forecast, by Patient Demographics

14.4.11.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.4.11.7. Market Revenue and Volume Forecast, by End-User

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Device Type

14.5.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.5.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.5.4. Market Revenue and Volume Forecast, by Component

14.5.5. Market Revenue and Volume Forecast, by Patient Demographics

14.5.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.5.7. Market Revenue and Volume Forecast, by End-User

14.5.8. Brazil

14.5.8.1. Market Revenue and Volume Forecast, by Device Type

14.5.8.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.5.8.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.5.8.4. Market Revenue and Volume Forecast, by Component

14.5.8.5. Market Revenue and Volume Forecast, by Patient Demographics

14.5.8.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.5.8.7. Market Revenue and Volume Forecast, by End-User

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Device Type

14.5.9.2. Market Revenue and Volume Forecast, by Application / Therapy Area

14.5.9.3. Market Revenue and Volume Forecast, by Technology / Stimulation Mode

14.5.9.4. Market Revenue and Volume Forecast, by Component

14.5.9.5. Market Revenue and Volume Forecast, by Patient Demographics

14.5.9.6. Market Revenue and Volume Forecast, by Price / Product Tier

14.5.9.7. Market Revenue and Volume Forecast, by End-User

Chapter 15. Company Profiles

15.1. Medtronic plc

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Abbott Laboratories

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Boston Scientific Corporation

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Nevro Corp.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. LivaNova PLC

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Axonics, Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. NeuroPace, Inc

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Nuvectra Corporation

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Aleva Neurotherapeutics SA

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Synapse Biomedical Inc.

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The internal neuromodulation devices market size is expected to increase from USD 11.82 billion in 2024 to USD 48.45 billion by 2034.

The internal neuromodulation devices market is expected to grow at a compound annual growth rate (CAGR) of around 15.15% from 2025 to 2034.

The major players in the internal neuromodulation devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Nevro Corp., LivaNova PLC, Axonics, Inc., NeuroPace, Inc, Nuvectra Corporation, Aleva Neurotherapeutics SA, Synapse Biomedical Inc., NeuroSigma, Inc., Inspire Medical Systems, Inc., Saluda Medical Pty Limited, Mainstay Medical International plc, and Biotronik SE & Co. KG.

The driving factors of the internal neuromodulation devices market are the escalating burden of neurological and chronic pain disorders, which remain refractory to traditional therapeutics.

North America region will lead the global internal neuromodulation devices market during the forecast period 2025 to 2034.